Praxis Precision Medicines, Inc. Common Stock (PRAX) Stock
NASDAQ · PRAX
301.58
Fundamentals
Market cap
$8.67B
Price / Earnings ratio
-25.4x
Price / Sales ratio
1102.2x
Price / Book ratio
6.4x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Praxis Precision Medicines, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees168
CEOMr. Marcio Silva De'Souza M.B.A.
IPO DateOct 16, 2020
HeadquartersBoston, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Marcio Silva De'Souza M.B.A. | President, CEO & Director | 1979 |
| Mr. Timothy Edwin Kelly | CFO & Treasurer | 1973 |
| Mr. Alex Nemiroff J.D. | General Counsel & Secretary | 1979 |
| Dr. Steven Petrou B.Sc. (Hons.), Ph.D. | Co-Founder and President of Research & Development | — |
| Ms. Megan T. Sniecinski | Chief Operating Officer | 1981 |
| Dr. Karl Hansen Ph.D. | Chief Technical Operations Officer | — |
| Ms. Kelly McCue | Chief People Officer | — |
| Ms. Alyssa J. S. Wyant | Chief Regulatory & Quality Officer | 1975 |
| Mr. Brian Spar | Chief of Staff | — |
| Dr. Orrin Devinsky M.D., Ph.D. | Head of Clinical Strategy | 1958 |
Fundamentals
Valuation
Market cap$8.67B
Price-to-sales ratio1,102.18
Price-to-book value6.43
Price-earnings ratio-25.40
Return on Equity-43.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-12.94
Income Statement
Average volume329,254
EBITDA$-325.41M
1 year high (52w)$392.70
1 year low (52w)$41.78
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



